Your session is about to expire
← Back to Search
Medical Food
Enteral Tube-fed Adults for Tube Feeding
N/A
Waitlist Available
Research Sponsored by Nestlé
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 14 days
Awards & highlights
Study Summary
This trial will study a new, high protein enteral formula to see if it meets nutrition goals for patients who cannot eat by mouth.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 14 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~14 days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Calorie nutritional goals
Secondary outcome measures
Adverse events
Daily reports of gastrointestinal intolerance
Protein nutritional goals
Trial Design
1Treatment groups
Experimental Treatment
Group I: Enteral Tube-fed AdultsExperimental Treatment1 Intervention
Adults being fed an enteral formula with a feeding tube
Find a Location
Who is running the clinical trial?
NestléLead Sponsor
321 Previous Clinical Trials
60,683 Total Patients Enrolled
2 Trials studying Tube Feeding
50 Patients Enrolled for Tube Feeding
Société des Produits Nestlé (SPN)Lead Sponsor
337 Previous Clinical Trials
62,536 Total Patients Enrolled
2 Trials studying Tube Feeding
50 Patients Enrolled for Tube Feeding
Krysmaru Araujo Torres, MDStudy DirectorNestle Health Science
3 Previous Clinical Trials
46 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Enteral Tube-fed Adults
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger